These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 34668657)

  • 21. Efficiency of fenofibrate in facilitating the reduction of central macular thickness in diabetic macular edema.
    Srinivasan S; Hande P; Shetty J; Murali S
    Indian J Ophthalmol; 2018 Jan; 66(1):98-105. PubMed ID: 29283132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal variation of optical coherence tomography biomarkers as predictors of anti-VEGF treatment outcomes in diabetic macular edema.
    Maggio E; Mete M; Sartore M; Bauci F; Guerriero M; Polito A; Pertile G
    Graefes Arch Clin Exp Ophthalmol; 2022 Mar; 260(3):807-815. PubMed ID: 34661731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of macular oedema on the measurement of macular pigment optical density.
    Thiele S; Rauscher FG; Wiedemann P; Dawczynski J
    Graefes Arch Clin Exp Ophthalmol; 2016 Mar; 254(3):455-65. PubMed ID: 26100452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial macular thickness and response to treatment in diabetic macular edema.
    Soheilian M; Ramezani A; Yaseri M; Mirdehghan SA; Obudi A; Bijanzadeh B
    Retina; 2011 Sep; 31(8):1564-73. PubMed ID: 21451442
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracystic hyperreflective material in centre-involving diabetic macular oedema.
    Venkatesh R; Sangai S; Reddy NG; Sridharan A; Pereira A; Aseem A; Gadde SGK; Yadav NK; Chhablani J
    Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2533-2544. PubMed ID: 33710472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CHANGES IN CENTRAL CHOROIDAL THICKNESS AFTER TREATMENT OF DIABETIC MACULAR EDEMA WITH INTRAVITREAL BEVACIZUMAB CORRELATION WITH CENTRAL MACULAR THICKNESS AND BEST-CORRECTED VISUAL ACUITY.
    Nourinia R; Ahmadieh H; Nekoei E; Malekifar P; Tofighi Z
    Retina; 2018 May; 38(5):970-975. PubMed ID: 28426622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HbA1c as a predictor for response of bevacizumab in diabetic macular oedema.
    Sharma S; Joshi SN; Karki P
    BMJ Open Ophthalmol; 2020; 5(1):e000449. PubMed ID: 32426522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal aflibercept for diabetic macular oedema in real-world: 36-month visual acuity and anatomical outcomes.
    Lukic M; Williams G; Shalchi Z; Patel PJ; Hykin PG; Hamilton RD; Rajendram R
    Eur J Ophthalmol; 2021 May; 31(3):1201-1207. PubMed ID: 32429690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identifying central serous chorioretinopathy biomarkers in coexisting diabetic retinopathy: a multimodal imaging study.
    Dhurandhar DS; Singh SR; Sahoo NK; Goud A; Lupidi M; Chhablani J
    Br J Ophthalmol; 2020 Jul; 104(7):904-909. PubMed ID: 31563867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optical coherence tomography in diabetic macular edema: patterns and related risk factors.
    Ahmadpour-Baghdadabad M; Manaviat M; Shojaoddiny-Ardekani A
    Nepal J Ophthalmol; 2013; 5(2):190-4. PubMed ID: 24172553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Diabetic Macular Edema on Repeatability of Retinal Nerve Fiber Layer Thickness Measurements at the Macular and Peripapillary Area Using Swept-Source Optical Coherence Tomography.
    Min JK; Lee S; Kim JS; Woo JM; Yang HS
    Curr Eye Res; 2017 Feb; 42(2):307-314. PubMed ID: 27347610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are we making good use of our public resources? The false-positive rate of screening by fundus photography for diabetic macular oedema.
    Wong RL; Tsang CW; Wong DS; McGhee S; Lam CH; Lian J; Lee JW; Lai JS; Chong V; Wong IY
    Hong Kong Med J; 2017 Aug; 23(4):356-64. PubMed ID: 28684650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced depth imaging optical coherence tomography in type 2 diabetes.
    Querques G; Lattanzio R; Querques L; Del Turco C; Forte R; Pierro L; Souied EH; Bandello F
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6017-24. PubMed ID: 22879414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic contribution of inflammatory mediators to the severity of diabetic and uveitic macular edema.
    Figueras-Roca M; Matas J; Llorens V; Sala-Puigdollers A; Navarro M; Zarranz-Ventura J; Adán A; Molins B
    Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2695-2705. PubMed ID: 33710470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation Between Visual Function and Photoreceptor Integrity in Diabetic Macular Edema: Spectral-Domain Optical Coherence Tomography.
    Shen Y; Liu K; Xu X
    Curr Eye Res; 2016; 41(3):391-9. PubMed ID: 25897822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of mean macular thickness using optical coherence tomography and visual acuity in diabetic retinopathy.
    Hussain A; Hussain N; Nutheti R
    Clin Exp Ophthalmol; 2005 Jun; 33(3):240-5. PubMed ID: 15932526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of macular hydration in the evaluation of the effect of intravitreal triamcinolone on visual acuity in eyes with diabetic macular edema.
    Sonmez K; Tezel TH; Kaplan HJ
    Int Ophthalmol; 2013 Feb; 33(1):15-25. PubMed ID: 22890369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optical coherence tomography for the detection of early macular edema in diabetic patients with retinopathy.
    Koleva-Georgieva DN; Sivkova NP
    Folia Med (Plovdiv); 2010; 52(1):40-8. PubMed ID: 20380286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic macular edema with pachychoroid features.
    Kang K; Lee H; Jang M; Kim HC; Chung H
    BMC Ophthalmol; 2020 Oct; 20(1):392. PubMed ID: 33008430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multifocal electroretinogram in diabetic macular edema and its correlation with different optical coherence tomography features.
    Khojasteh H; Riazi-Esfahani H; Khalili Pour E; Faghihi H; Ghassemi F; Bazvand F; Mahmoudzadeh R; Salabati M; Mirghorbani M; Riazi Esfahani M
    Int Ophthalmol; 2020 Mar; 40(3):571-581. PubMed ID: 31712927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.